propidium has been researched along with ribavirin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjelobaba, I; Bozic, I; Jovanovic, M; Laketa, D; Lavrnja, I; Nedeljkovic, N; Pekovic, S; Savic, D; Stojiljkovic, M | 1 |
1 other study(ies) available for propidium and ribavirin
| Article | Year |
|---|---|
Low-dose ribavirin treatments attenuate neuroinflammatory activation of BV-2 Cells by interfering with inducible nitric oxide synthase.
Topics: Animals; Annexin A5; Cell Shape; Cell Survival; Cytoskeleton; Dose-Response Relationship, Drug; Flow Cytometry; Inflammation; Lipopolysaccharides; Mice; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Propidium; Ribavirin; Tumor Necrosis Factor-alpha | 2015 |